annual press conference - zeiss.com€¦ · • portfolio supplemented. carl zeiss group, 2010...

Annual Press Conference

Carl Zeiss AGStuttgart, 2 December 2010

Dr. Dieter Kurz President & CEO

Dr. Michael Kaschke

Member of the Executive Board

2 December 2010 2Carl Zeiss Group, 2010 Annual Press Conference

Turnaround Achieved Overview: Fiscal year 2009/10

2

*without Carl Zeiss Visionand before auditor's certificate

+0.8%

+EUR 490 million

+42%

+52%

Change

12,971 12,872Employees (Head count excl. trainees)

30 SEP 2010* 30 SEP 2009

423 -67EbIT (Earnings before Interest and Taxes)

2,981 2,101Sales revenues

3,213 2,111Incoming orders

FY 2009/10* FY 2008/09in EUR million

-0.7%

+EUR 80 million

+9%

+24%

Change from FY 2009/10 to FY

2007/08

+EUR 369 million 208 -161Net income +EUR 30 million

2 December 2010 3Carl Zeiss Group, 2010 Annual Press Conference 3

New Strength through Stability and Flexibility Positive fiscal year 2009/10

Record year for Carl Zeiss:• Strategic decision to overcome the crisis paying off

• High level of flexibility of the Carl Zeiss Group enables fast and extensive utilization of economic upturn

• New products developed during the crisis successfully placed on the market

• Processes and cost structures optimized

• Employees kept on board to be able to react quickly to market opportunities during the upswing

• Portfolio supplemented

33


Carl Zeiss Group EUR 2,981 million revenue in fiscal year 2009/10

Busi

ness

Gro

ups

Medical systems Microscopy Semiconductor Technology

Industrial Metrology

Consumer Optics/Optronics

Carl Zeiss Vision (Joint Venture**)

Sale

s re

venu

es in

E

UREUR 754m EUR 397m EUR 1,187m EUR 292m EUR 881m

Carl Zeiss AG

*Over previous year

EUR 312m

4

Mar

kets

+7%* +9%* +207%* -4%* +3%* +0.2%*

+10%* +14%* +279%* +28%* -21%*

Inco

min

g or

ders

Medical and Research Solutions

Industrial Solutions Lifestyle Products

** valued at equity in the 2009/10 financial statements of the Carl Zeiss Group.


Semiconductor Technology Group Sales revenue reaches record level

Employees (FTE)

Sales revenues in EUR million

5

*Over previous year 30 SEP 07

30 Sep 08

30 SEP 09

2,496 2,670 2,530

30 SEP 06

2,1992,551

30 SEP 10

+207%*

2005/06 2006/07 2007/08 2008/09

864

1,042 1,018

386

1,187

2009/10


Semiconductor Technology Group EUV lithography: ASML installs first system at chip manufacturer

6

EUV lithography is the next generation chip fabrication technology.

EUV technology enables a new generation of microchips with structures in the 20 nanometer range and below.

This results in very compact, powerful chips and a considerable reduction in fabrication costs.

Dutch manufacturer of chip exposure machines ASML, which is supplied with optical systems for EUV lithography exclusively by Carl Zeiss, installed the first EUV system at a leading chip manufacturer in December.


Medical Systems Group Pushing ahead on course of growth

Employees (FTE)

*Over previous year

The values deviate from the published figures of Carl Zeiss Meditec AG as a result of different consolidation models.


7

2,2742,467 2,759 2,785 2,878

+7%*

631 638 661 706754

30 SEP 07

30 SEP 08

30 SEP 09

30 SEP 06

30 SEP 10

2005/06 2006/07 2007/08 2008/09 2009/10


Medical Systems Group Integrated systems for optimal results

This business group is increasingly evolving into an integrated solutions provider and delivers a combination of products, applications and services.

Integrated diagnostic, treatment and surgical systems in ophthalmology are improving therapeutic success.

For example, the ZEISS toric solution offers optimally matched instruments and applications. Doctors can more efficiently perform cataract operations, even on patients with astigmatism.

The preparation time needed to measure the eyes and insert the toric lenses is considerably reduced. All required data is available in the OR at the push of a button.



Microscopy Group Expansion of instrument portfolio contributed to success

Employees (FTE)


9

*Over previous year 30 SEP 07

30 SEP 08

30 SEP 09

30 SEP 06

30 SEP 10

2005/06 2006/07 2007/08 2008/09 2009/10

1,5621,758 1,731 1,677 1,720

+9%*

340 323 339365

397



Microscopy Group New systems for research, and routine and industrial applications

Carl Zeiss has entered into a special collaboration between research and industry with Harvard University:

Carl Zeiss delivers microscope systems for a research lab. An employee of the company provides on-site support.

Harvard benefits from the latest technology and Carl Zeiss receives information from users, which is then integrated into system development.

1010


Industrial Metrology Group Upswing felt in second half of the year


Employees (FTE)

*Over previous year

11

30 SEP 07

30 SEP 08

30 SEP 09

30 SEP 06

30 SEP 10

2005/06 2006/07 2007/08 2008/09 2009/10

1,2861,509

1,803 1,749 1,765

-4%*

278316

374

304 292



Industrial Metrology Group Acquiring new market segments

Carl Zeiss constantly invests in research and development to enable it to bring products to market sooner and open up new customer and market segments: such as the plastics and medical technology industries.

With the METROTOM® computer tomograph and the O-INSPECT coordinate measuring machine, the business group offers solutions specially tailored to the demands of these industries.

12


Consumer Optics/Optronics Group Stable revenue trend


Employees (FTE)

*Over previous year

13

30 Sep 07

30 SEP 08

30 SEP 09

30 SEP 06

30 SEP 10

2005/06 2006/07 2007/08 2008/09 2009/10

1,2031,504 1,510 1,524 1,504

+3%*

234 245

309 304 312


Binoculars for the Most Demanding Users Reliability and best vision under all circumstances

Adventurer and travel photographer Jürgen Sedlmayer and his wife toured the Upper Mustang region of the Himalayas for six weeks.

With their three horses, they crossed rivers, avoided landslides and mastered other challenges.

The binoculars on the trip: Victory 10 x 32 T* FL from Carl Zeiss.

14


Employees (FTE)

**Over previous year

* Not consolidated in the financial statement of the Carl Zeiss Group

Sales revenues* in EUR million

15

Carl Zeiss Vision Joint Venture Positioning in international competition improved

30 SEP 07

30 SEP 08

30 SEP 09

30 SEP 06

30 SEP 10

2005/06 2006/07 2007/08 2008/09 2009/10

+0.2%**

845 844 892 879 881

10,626 10,293

12,83011,659 11,586



MyoVision First effective treatment for shortsighted children in Asia

Almost half of Asian children suffer from myopia, the term used to describe genetically induced shortsightedness that can deteriorate with age to the point of blindness.

With MyoVision™, Carl Zeiss Vision launched lenses specially developed for the Asian market in the summer of 2010.

These new lenses decisively slow the progression of the condition by an average of 30 percent in children between six and twelve years of age and therefore offer an effective aid for the treatment of myopia for the very first time.

16


Equity Ratio Reached 33 Percent Again Financial stability and economic independence

Equity ratio In % of the balance sheet total

17

30%

20%

10%

22

3033

2933

30 SEP 07 30 SEP 08 30 SEP 0930 SEP 06 30 SEP 100%


Gross cash flow* Restrengthend Cost management of past year bearing fruit

EUR million

*Determined following the recommendation of the German Financial Analysis Association/Schmalenbach- Gesellschaft

18

17% 21% 18% 4% 17%Share of revenues

2005/06 2006/07 2007/08 2008/09

410

549496

76

506

2009/10


Net Liquid Assets: EUR 884 million Solid foundation for the long-term growth strategy

19

Net liquid assetsin EUR million

275

612 615

478

884

30 SEP 06 30 SEP 07 30 SEP 08 30 SEP 09 30 SEP 10


Capital Expenditure and Depreciation of property, plant and equipment

EUR million

20

118

107

118

80

9699

114

9599

53

DepreciationInvestments



Investments in the Future Expenditures for research and development

During the reporting period, Carl Zeiss generated half its revenues with products that are less than three years old.

21

254290

321284 291

EUR million

10% 11% 12% 14% 10%Share of revenues



Outlook for Fiscal Year 2010/11 Integration Carl Zeiss Vision enhances international presence

22

More employees outside Germany for first timeConsiderably stronger presence of the ZEISS brand among end consumersSynergies in healthcare markets

Active in 30 countries

More than 40 production sites and 50 sales companies

Approx. 24,000 employees (13,000) outside Germany


Outlook for Fiscal Year 2010/11 Systematically utilize market opportunities

• Actively and systematically take advantage of growth opportunities in Asia

• Manage dynamism and volatility of the markets with flexible structures

• Drive integration of Carl Zeiss Vision as Vision Care business group

• Further strengthen the ZEISS brand in the global arena

23


Continuity and New Impulse Change to the Carl Zeiss AG Executive Board

Dr. Dieter KurzPresident & CEO(until 31 Dec 2010)

24

Dr. Michael KaschkePresident & CEO(from 1 Jan 2011)

Medical systems

Microscopy

Vision Care

Strategic Development

Communications

Human Resources

Asia/Australia

Dr. Hermann Gerlinger

Semiconductor Technology

Industrial Metrology

Production

Global Supply Chain

Research & Technology

Americas

Thomas Spitzenpfeil(CFO)

Consumer Optics/Optronics

Finance/Financial Controlling & Taxes

Business Process Excellence

Auditing & Risk Management

Legal and Patents

Financial Services

Financial Accounting Center

Business Services & Infrastructure

Europe/Africa

annual press conference - zeiss.com€¦ · • portfolio supplemented. carl zeiss group, 2010...

Documents